# ENTPD6

## Overview
ENTPD6, or ectonucleoside triphosphate diphosphohydrolase 6, is a gene that encodes a type II transmembrane protein involved in the hydrolysis of nucleoside triphosphates and diphosphates. This protein is a member of the NTPDase family, which plays a critical role in regulating extracellular nucleotide levels and purinergic signaling, impacting various physiological processes such as neurotransmission, inflammation, and thromboregulation (Möller2007Monitoring; Naito2011Ectonucleoside). ENTPD6 is primarily localized in the endoplasmic reticulum, Golgi apparatus, and plasma membrane, and can also be secreted through proteolytic cleavage. Its enzymatic activity is essential for maintaining cellular homeostasis by controlling the availability of extracellular nucleotides, which are crucial for cellular signaling pathways (Naito2011Ectonucleoside). Despite its involvement in these fundamental processes, the specific roles and clinical significance of ENTPD6 in human health and disease remain largely unexplored.

## Function
ENTPD6, or ectonucleoside triphosphate diphosphohydrolase 6, is an enzyme that plays a role in the hydrolysis of nucleoside triphosphates and diphosphates into monophosphates, thereby regulating extracellular nucleotide levels and influencing purinergic signaling. This enzyme is part of the NTPDase family, which is involved in modulating various physiological processes, including neurotransmission, inflammation, and thromboregulation (Möller2007Monitoring).

ENTPD6 is a type II transmembrane protein that is primarily localized in the endoplasmic reticulum, Golgi apparatus, and plasma membrane. It can also be secreted through proteolytic cleavage (Naito2011Ectonucleoside). The enzyme's activity on the cell surface is crucial for controlling the availability of extracellular nucleotides, which are important for cellular signaling pathways (Möller2007Monitoring).

In healthy human cells, ENTPD6 is involved in regulating nucleotide-mediated signaling by controlling the degradation of nucleotides like ATP and the formation of nucleosides such as adenosine. This regulation is essential for maintaining cellular homeostasis and proper physiological function (Naito2011Ectonucleoside). The specific roles of ENTPD6 in healthy tissues, however, remain largely unexplored.

## Clinical Significance
ENTPD6 has been implicated in various conditions through genome-wide association studies (GWAS) and other research. A study identified a significant association between a single nucleotide polymorphism (SNP) in the ENTPD6 gene and acute insulin response to glucose (AIRg) in Hispanic-Americans, suggesting a potential role in glucose homeostasis and insulin response (Rich2009A). Another GWAS linked ENTPD6 to irritable temperament, with a specific SNP showing suggestive significance (Gonda2021Genetic).

ENTPD6 has also been mentioned in the context of allergic diseases. It was identified as potentially phenotype-specific for allergic rhinitis and grass pollen sensitization (Portelli2014Genetic). In the realm of infertility, ENTPD6 was suggested to be involved in non-obstructive azoospermia (NOA) based on functional screening in yeast models (Ding2021Strategies).

Despite these associations, the clinical significance of ENTPD6 mutations or alterations remains largely unexplored, with no direct links to specific diseases established. The gene's role in purinergic signaling and its expression in various tissues, such as human epidermal melanocytes, has been studied, but without clear disease associations (Schultz2022Purinergic; Naasani2023Epidermal).


## References


[1. (Portelli2014Genetic) M. A. Portelli, E. Hodge, and I. Sayers. Genetic risk factors for the development of allergic disease identified by genome‐wide association. Clinical &amp; Experimental Allergy, 45(1):21–31, December 2014. URL: http://dx.doi.org/10.1111/cea.12327, doi:10.1111/cea.12327. This article has 143 citations.](https://doi.org/10.1111/cea.12327)

[2. (Ding2021Strategies) Xinbao Ding and John C. Schimenti. Strategies to identify genetic variants causing infertility. Trends in Molecular Medicine, 27(8):792–806, August 2021. URL: http://dx.doi.org/10.1016/j.molmed.2020.12.008, doi:10.1016/j.molmed.2020.12.008. This article has 11 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1016/j.molmed.2020.12.008)

[3. (Naasani2023Epidermal) Liliana Ivet Sous Naasani, Jéssica Gonçalves Azevedo, Jean Sévigny, Tiago Franco de Oliveira, Silvya Stuchi Maria-Engler, and Márcia Rosângela Wink. Epidermal melanocytes metabolize extracellular nucleotides by purinergic enzymes. Biochemistry and Cell Biology, 101(3):259–266, June 2023. URL: http://dx.doi.org/10.1139/bcb-2022-0058, doi:10.1139/bcb-2022-0058. This article has 0 citations.](https://doi.org/10.1139/bcb-2022-0058)

[4. (Rich2009A) S. S. Rich, M. O. Goodarzi, N. D. Palmer, C. D. Langefeld, J. Ziegler, S. M. Haffner, M. Bryer-Ash, J. M. Norris, K. D. Taylor, T. Haritunians, J. I. Rotter, Y.-D. I. Chen, L. E. Wagenknecht, D. W. Bowden, and R. N. Bergman. A genome-wide association scan for acute insulin response to glucose in hispanic-americans: the insulin resistance atherosclerosis family study (iras fs). Diabetologia, 52(7):1326–1333, May 2009. URL: http://dx.doi.org/10.1007/s00125-009-1373-0, doi:10.1007/s00125-009-1373-0. This article has 34 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1007/s00125-009-1373-0)

[5. (Möller2007Monitoring) Sina Möller, Caroline Jung, Sahil Adriouch, Gudrun Dubberke, Fabienne Seyfried, Michel Seman, Friedrich Haag, and Friedrich Koch-Nolte. Monitoring the expression of purinoceptors and nucleotide-metabolizing ecto-enzymes with antibodies directed against proteins in native conformation. Purinergic Signalling, 3(4):359–366, September 2007. URL: http://dx.doi.org/10.1007/s11302-007-9084-9, doi:10.1007/s11302-007-9084-9. This article has 20 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s11302-007-9084-9)

[6. (Naito2011Ectonucleoside) Seiji Naito. Ectonucleoside triphosphate diphosphohydrolase 6 expression in testis and testicular cancer and its implication in cisplatin resistance. Oncology Reports, April 2011. URL: http://dx.doi.org/10.3892/or.2011.1274, doi:10.3892/or.2011.1274. This article has 3 citations and is from a peer-reviewed journal.](https://doi.org/10.3892/or.2011.1274)

[7. (Gonda2021Genetic) Xenia Gonda, Nora Eszlari, Dora Torok, Zsofia Gal, Janos Bokor, Andras Millinghoffer, Daniel Baksa, Peter Petschner, Peter Antal, Gerome Breen, Gabriella Juhasz, and Gyorgy Bagdy. Genetic underpinnings of affective temperaments: a pilot gwas investigation identifies a new genome-wide significant snp for anxious temperament in adgrb3 gene. Translational Psychiatry, June 2021. URL: http://dx.doi.org/10.1038/s41398-021-01436-1, doi:10.1038/s41398-021-01436-1. This article has 12 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s41398-021-01436-1)

[8. (Schultz2022Purinergic) Iago C. Schultz, Ana Paula S. Bertoni, and Márcia R. Wink. Purinergic signaling elements are correlated with coagulation players in peripheral blood and leukocyte samples from covid-19 patients. Journal of Molecular Medicine, 100(4):569–584, January 2022. URL: http://dx.doi.org/10.1007/s00109-021-02175-y, doi:10.1007/s00109-021-02175-y. This article has 14 citations.](https://doi.org/10.1007/s00109-021-02175-y)